Department of Molecular Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.
Dis Markers. 2018 Feb 11;2018:7485942. doi: 10.1155/2018/7485942. eCollection 2018.
We evaluated the individual and combined levels of urine dipstick and total lymphocyte count (TLC) as surrogate markers for CD4 count in a low-resource community in Ghana. This cross-sectional study recruited 200 HIV-infected patients from the Saint Francis Xavier Hospital, Assin Fosu, Ghana. Complete blood count, CD4 count, and urine dipstick analysis were measured for participants. The threshold values were determined as <350 cells/l for CD4, <1200 cells/l for TLC, and ≥+ on urine dipstick analysis. The mean age of participants was 43.09 years. Proteinuria ≥ + [aOR = 4.30 (3.0-18.5)], leukocyturia ≥ + [aOR = 2.91 (1.33-12.5)], hematuria ≥ + [aOR = 2.30 (1.08-9.64)], and TLC < 1200 cells/l [aOR = 3.26 (3.94-15.29)] were significantly associated with increased risk of CD4 count < 350 cells/l. Using the individual markers, the best substitute marker for predicting CD4 count < 350 cells/l was proteinuria at a cutoff point ≥ 2++, AUC of 0.973, sensitivity of 97.6%, specificity of 100.0%, PPV of 100.0%, and NPV of 89.1%. A combination of ≤ 1200 TLC + ≥ 2++ (leukocyturia + proteinuria + hematuria) yielded an AUC of 0.980, sensitivity (72.8%), specificity (100.0%), PPV (100.0%), and NPV (97.9%). Proteinuria could serve as a noninvasive screening tool, but the combination of proteinuria, leukocyturia, hematuria, and TLC serves as a better substitute marker for CD4 count in monitoring the disease progression among HIV patients in low-resource communities.
我们评估了尿液干化学分析和总淋巴细胞计数(TLC)在加纳资源匮乏社区作为 CD4 计数替代标志物的个体和联合水平。这项横断面研究招募了来自加纳 Assin Fosu 的圣弗朗西斯泽维尔医院的 200 名 HIV 感染患者。对参与者进行了全血细胞计数、CD4 计数和尿液干化学分析。阈值确定为 CD4<350 个细胞/l、TLC<1200 个细胞/l 和尿液干化学分析≥+。参与者的平均年龄为 43.09 岁。蛋白尿≥+[比值比(aOR)=4.30(3.0-18.5)]、白细胞尿≥+[aOR=2.91(1.33-12.5)]、血尿≥+[aOR=2.30(1.08-9.64)]和 TLC<1200 个细胞/l[aOR=3.26(3.94-15.29)]与 CD4 计数<350 个细胞/l 的风险增加显著相关。使用单个标志物,预测 CD4 计数<350 个细胞/l 的最佳替代标志物是蛋白尿,截断值≥2++,AUC 为 0.973,敏感性为 97.6%,特异性为 100.0%,阳性预测值为 100.0%,阴性预测值为 89.1%。TLC≤1200+≥2++(白细胞尿+蛋白尿+血尿)的组合产生 AUC 为 0.980,灵敏度(72.8%)、特异性(100.0%)、阳性预测值(100.0%)和阴性预测值(97.9%)。蛋白尿可以作为一种非侵入性的筛查工具,但蛋白尿、白细胞尿、血尿和 TLC 的组合是资源匮乏社区 HIV 患者监测疾病进展的更好替代 CD4 计数标志物。